American Century Companies Inc Abcam PLC Transaction History

American Century Companies Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$21.54 - $24.41 $3.89 Million - $4.41 Million	-180,676 Reduced 58.14%	130,089 $2.94 Million
Q2 2023 Aug 14, 2023	SELL	$12.62 - $24.47 $3.3 Million - $6.4 Million	-261,458 Reduced 45.69%	310,765 $7.6 Million
Q1 2023 May 11, 2023	BUY	$12.98 - $17.1 $3.56 Million - $4.69 Million	273,986 Added 91.87%	572,223 $7.7 Million
Q4 2022 Feb 13, 2023	BUY	$13.92 - $17.0 $4.15 Million - $5.07 Million	298,237 New	298,237 $4.64 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.